Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Theodorescu

Showing results (141-150 of 275) with videos related to

Pageof 28
Sort By:
Biochemical and Biophysical Research Communications|November 28, 2006
A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancerMikael Herlevsen, Gary Oxford, Celeste Ptak, et al.
Oncogene|February 28, 2003
Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of actionDora Bigler, Kay M Gulding, Roger Dann, et al.
Molecular Cancer Therapeutics|August 13, 2009
Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate modelJill K Slack-Davis, E Daniel Hershey, Dan Theodorescu, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2016
Synthesis of novel Ral inhibitors: An in vitro and in vivo studyChao Yan, Dan Theodorescu, Bettina Miller, et al.
International Journal of Molecular Sciences|September 23, 2022
AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder CancerNeeraj Agarwal, Qiong Zhou, Deepak Arya, et al.
The Journal of Urology|September 6, 2022
Clinical and Preclinical Therapies for Bladder Cancer Following Bacillus Calmette-Guérin FailureMichael Nazmifar, Cheyenne Williams, Aurash Naser-Tavakolian, et al.
Nature Reviews. Urology|June 28, 2022
The dynamic roles of the bladder tumour microenvironmentYu-Cheng Lee, Hung-Ming Lam, Charles Rosser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancerDan Theodorescu, L M Sapinoso, M R Conaway, et al.
Oncotarget|April 24, 2018
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growthCraig S Richmond, Darby Oldenburg, Garrett Dancik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2009
Src phosphorylation of RhoGDI2 regulates its metastasis suppressor functionYimin Wu, Konstadinos Moissoglu, Hong Wang, et al.
Pageof 28

Showing results (141-150 of 275) with videos related to

Sort By:
Pageof 28
Biochemical and Biophysical Research Communications|November 28, 2006
A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancerMikael Herlevsen, Gary Oxford, Celeste Ptak, et al.
Oncogene|February 28, 2003
Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of actionDora Bigler, Kay M Gulding, Roger Dann, et al.
Molecular Cancer Therapeutics|August 13, 2009
Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate modelJill K Slack-Davis, E Daniel Hershey, Dan Theodorescu, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2016
Synthesis of novel Ral inhibitors: An in vitro and in vivo studyChao Yan, Dan Theodorescu, Bettina Miller, et al.
International Journal of Molecular Sciences|September 23, 2022
AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder CancerNeeraj Agarwal, Qiong Zhou, Deepak Arya, et al.
The Journal of Urology|September 6, 2022
Clinical and Preclinical Therapies for Bladder Cancer Following Bacillus Calmette-Guérin FailureMichael Nazmifar, Cheyenne Williams, Aurash Naser-Tavakolian, et al.
Nature Reviews. Urology|June 28, 2022
The dynamic roles of the bladder tumour microenvironmentYu-Cheng Lee, Hung-Ming Lam, Charles Rosser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancerDan Theodorescu, L M Sapinoso, M R Conaway, et al.
Oncotarget|April 24, 2018
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growthCraig S Richmond, Darby Oldenburg, Garrett Dancik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2009
Src phosphorylation of RhoGDI2 regulates its metastasis suppressor functionYimin Wu, Konstadinos Moissoglu, Hong Wang, et al.
Pageof 28